• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

19
1
1
1
1

COUNTRY

1

CATEGORIES

  • 9
  • 8
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

1
5
9
29

PUBLISHED

0
1
1
29

PRODUCT TYPE

24
5

Search "Pharmexa A/S-Company Report" returned 29 results.

PRODUCT TITLE
Pharmexa Acquisition Manual Pharmexa Acquisition Manual - Product Thumbnail Image

Pharmexa Acquisition Manual

The Acquisition Manual on Pharmexa is published for two purposes, firstly to identify the company as a potential acquisition target and secondly, to fully analyse all aspects of Pharmexa so that potential...

May 2015
Pancreatic Cancer Drugs - Global Strategic Business Report Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

This report analyzes the Global market for Pancreatic Cancer Drugs in US$ Million Annual forecasts are provided for the period 2006 through 2015 The report profiles 57 companies including Abraxis BioScience,...

April 2010
FROM

Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape

“Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotech Clusters, Funding Characteristics and Regulatory Landscape ” report provides an overview of the small and medium...

February 2010
FROM
Cancer Peptides: From First-in-Class to Best-in-Class? Cancer Peptides: From First-in-Class to Best-in-Class? - Product Thumbnail Image

Cancer Peptides: From First-in-Class to Best-in-Class?

This report gives you a new and unique way of stratifying and analyzing the global peptide pipeline in cancer towards personalized medicine and presents actionable analysis which allows you to discover:...

January 2013
FROM
Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing breast cancer drug development Find out whether you are number one, two or further down the ladder...

August 2012
FROM
Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Pancreatic Cancer Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing pancreatic cancer drug development Find out whether you are number one, two or further down the ladder...

March 2012
FROM
Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Commercializing Peptides in Cancer: The Faster Route to Consider Your Options and Position of Others

This report will excel your competitive awareness and decrease your decision making time in managing peptide drug development in cancer Find out whether you are number one, two or further down the ladder...

November 2011
FROM
Human Vaccines - Global Strategic Business Report Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines The report...

March 2012
FROM
Cancer Vaccines: From First-in-Class to Best-in-Class? Cancer Vaccines: From First-in-Class to Best-in-Class? - Product Thumbnail Image

Cancer Vaccines: From First-in-Class to Best-in-Class?

This report gives you a new and unique way of stratifying and analyzing the global cancer vaccine pipeline and presents actionable analysis which allows you to discover: - Where the competition is;...

March 2013
FROM
Cancer Vaccines: Measuring Market Potential Cancer Vaccines: Measuring Market Potential - Product Thumbnail Image

Cancer Vaccines: Measuring Market Potential

This brand new report published in October 2004 provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets. Vaccine product...

October 2004
FROM
Infectious Vaccines Partnering Terms and Agreements Infectious Vaccines Partnering Terms and Agreements - Product Thumbnail Image

Infectious Vaccines Partnering Terms and Agreements

The Infectious Vaccines Partnering Terms and agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals...

December 2013
FROM
Bladder Cancer Therapeutics - Global Strategic Business Report Bladder Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bladder Cancer Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and Rest of World. Annual estimates...

October 2010
FROM
Drug Delivery Technology - Developing a New Generation of Vaccines Drug Delivery Technology - Developing a New Generation of Vaccines - Product Thumbnail Image

Drug Delivery Technology - Developing a New Generation of Vaccines

“Over the past year, excitement within the industry has been growing as companies start to recognize the potential of vaccines New insights into immunobiology and delivery systems may allow the development...

November 2007
FROM
Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others - Product Thumbnail Image

Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others

This report represents a new and unique way of stratifying and analyzing the global protein kinase drug pipeline in oncology towards personalized medicine It will excel your competitive awareness and...

May 2012
FROM
A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market - Product Thumbnail Image

A Decision Support Tool for Optimizing The Colorectal Cancer Pipeline: From Research and Development to Market

This report comprises defined and up to date development strategies for 347 colorectal cancer drugs within the portfolio of 182 companies, from Ceased to Marketed The report extensively analyses their...

March 2011
FROM
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market - Product Thumbnail Image

Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market

This report comprises defined and up to date development strategies for 416 lung cancer drugs within the portfolio of 217 companies, from Ceased to Marketed The report extensively analyses their 241...

July 2011
FROM
H. Lundbeck A/S - Product Pipeline Review - 2012 H. Lundbeck A/S - Product Pipeline Review - 2012 - Product Thumbnail Image

H. Lundbeck A/S - Product Pipeline Review - 2012

H. Lundbeck A/S – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “H. Lundbeck A/S - Product Pipeline Review - 2012” provides data on the H. Lundbeck A/S’s research...

May 2012
FROM
Cancer Therapies - Global Strategic Business Report Cancer Therapies - Global Strategic Business Report - Product Thumbnail Image

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

October 2011
FROM
H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review Summary H Lundbeck A/S (Lundbeck) is a pharmaceutical company, engaged in the research, development, manufacturing and marketing...

April 2011
FROM
Biogen Idec Inc. - Product Pipeline Review - H2 2011 Biogen Idec Inc. - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Biogen Idec Inc. - Product Pipeline Review - H2 2011

Biogen Idec Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Biogen Idec Inc. - Product Pipeline Review - H2 2011” provides data on the Biogen Idec...

November 2011
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office